Autolus Therapeutics Income Statement (2017-2025) | AUTL

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.02B0.02B0.02B
Gross Profit (Quarter)
0.01B-0.01B-0.01B-0.00B-0.01B-0.00B
Operating items
Research & Development (Quarter)
-0.03B0.03B-32.29B0.21B0.03B0.03B0.03B0.01B0.03B0.03B0.03B0.04B0.03B0.04B0.04B0.03B0.03B0.03B0.03B0.04B
Share-based Compensation (IS) (Quarter)
Selling, General & Administrative (Quarter)
-0.01B-0.01B-8.30B0.06B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.04B0.04B
Other Operating Expenses (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.03B
Operating Expenses (Quarter)
-0.04B-0.04B-40.35B0.26B-0.04B-0.05B-0.04B0.01B-0.04B-0.05B-0.05B0.32B0.05B0.06B0.07B0.08B0.07B0.08B0.09B0.10B
Operating Income (Quarter)
-0.04B-0.04B-0.04B-0.01B-0.04B-0.04B-0.04B-0.05B-0.04B-0.06B-0.07B-0.08B-0.07B-0.06B-0.07B-0.07B
EBIT (Quarter)
-0.04B-0.04B-39.38B-0.02B-0.04B-0.04B-0.04B-0.01B-0.04B-0.04B-0.04B-0.05B-0.04B-0.06B-0.07B-0.08B-0.07B-0.06B-0.07B-0.07B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.03B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.00B
Other Non Operating Income (Quarter)
0.00B-0.00B0.95B-0.00B-0.00B-0.00B0.01B0.00B0.00B-0.00B0.00B-0.00B0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B
Non Operating Income (Quarter)
0.00B-0.00B0.98B-0.00B0.00B-0.00B-0.01B-0.00B-0.00B-0.00B0.00B-0.02B-0.00B0.00B-0.01B0.02B-0.00B0.00B0.00B-0.00B
Net income details
EBT (Quarter)
-0.04B-0.04B-39.38B-0.02B-0.04B-0.04B-0.04B-0.01B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Tax Provisions (Quarter)
0.01B0.01B5.38B-0.02B-0.00B-0.00B-0.00B0.02B-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B
Profit After Tax (Quarter)
0.03B0.03B0.03B-0.24B0.04B-0.04B0.04B-0.03B0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Income from Continuing Operations (Quarter)
-0.04B-0.05B-44.76B-0.01B-0.04B-0.04B-0.04B-0.03B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Consolidated Net Income (Quarter)
-0.04B-0.05B-44.76B-0.01B-0.04B-0.04B-0.04B-0.03B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Income towards Parent Company (Quarter)
-0.04B-0.05B-44.76B-0.01B-0.04B-0.04B-0.04B-0.03B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Net Income towards Common Stockholders (Quarter)
-0.03B-0.03B-33.99B-0.01B-0.04B-0.04B-0.04B-0.03B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B-0.09B
Additional items
EPS (Basic) (Quarter)
0.530.470.47-3.43-0.41-0.46-0.47-0.23-0.23-0.26-0.26-0.45-0.24-0.22-0.31-0.09-0.26-0.18-0.30-0.34
EPS (Weighted Average and Diluted) (Quarter)
0.530.470.47-3.43-0.41-0.46-0.47-0.23-0.23-0.26-0.26-0.45-0.24-0.22-0.31-0.09-0.26-0.18-0.30-0.34
Shares Outstanding (Weighted Average) (Quarter)
0.06B0.07B0.07B90.91B0.09B0.09B0.09B0.09B0.17B0.17B0.17B0.17B0.22B0.27B0.25B0.26B0.27B0.27B
Shares Outstanding (Diluted Average) (Quarter)
0.06B0.07B0.07B0.09B0.09B0.09B0.09B0.17B0.17B0.17B0.17B0.22B0.26B0.25B0.26B0.27B0.27B
EBITDA (Quarter)
0.03B0.03B0.04B-0.25B-0.04B-0.06B-0.06B-0.02B-0.03B-0.04B-0.05B-0.07B-0.05B-0.06B-0.06B-0.06B-0.06B-0.03B-0.08B-0.09B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.03B0.02B0.01B0.01B-0.03B0.01B-0.01B0.01B0.02B
Shares Outstanding (Quarter)
0.09B0.09B0.09B0.00B0.09B1.000.00B0.17B1.000.27B0.27B0.09B0.00B0.00B
Tax Rate (Quarter)
-14.68-16.08-13.6871.930.070.130.01-263.160.04-0.090.050.030.02-0.09-0.03-5.59-3.28-0.84-0.681.29